Home | Drugs Approvals and Trials

Drugs Approvals and Trials

Study of Generic Antiepilepsy Drugs Finds Minimal Differences

CINCINNATI—A comparison of two of the most disparate approved generic antiepileptic drugs found minimal differences when compared under rigorous testing procedures in ...

Penn Medicine Researchers Announce Latest Results of Investigational Cellular Therapy CTL019

Findings Include Response Rates Over 90 Percent in Pediatric Acute Lymphoblastic Leukemia, and First Results of Non-Hodgkin Lymphoma Trial ...

Spaces are still being sought for a first of a kind international study to help women with Polycystic Ovary Syndrome (PCOS)

Spaces are still available for women to take part in a groundbreaking international study looking at whether a drug which helps diabetic patients lose weight could also help them. ... Full story

Booster Ebola vaccine enters first trials at Oxford University

Oxford University scientists have begun testing the safety of a candidate booster vaccine against Ebola, to find out whether it could further increase the immune responses seen in 30 healthy volunteers. ... Full story

Knee pain research extended to Fife

Volunteers sought for study ... Full story

NIH ends Transcranial Doppler (TCD) with Transfusions Changing to Hydroxyurea (TWiTCH) clinical trial due to early results

What The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has ended the Transcranial Doppler (TCD) with Transfusions Changing to Hydroxyurea (TWiTCH) clinical trial early in agreement with the recommendations of the Data and Safety Monitoring Board (DSMB). ... Full story

VCU researchers to study vitamin C as treatment for hemorrhagic shock

The Department of Defense has awarded a $1 million grant to Virginia Commonwealth University researchers to test the use of vitamin C in preventing hemorrhagic shock-induced death. ... Full story

NIH Begins Early Human Clinical Trial of VSV Ebola Vaccine

​ Human testing of a second investigational Ebola vaccine candidate is under way at the National Institutes of Health’s Clinical Center in Bethesda, Maryland. ... Full story

Drug for Rare Blood Disorder Developed at Penn Receives Orphan Drug Status from European Union

PHILADELPHIA — A Penn Medicine-developed drug has received orphan status in Europe this week for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare, life-threatening disease that causes anemia due to destruction of red blood cells and thrombosis. ... Full story

FDA approves U-M-invented drug for Gaucher disease

ANN ARBOR, Mich. — Cerdelga, a treatment for Gaucher disease type 1 developed at the University of Michigan Medical School and licensed to Genzyme Corp., has been approved by the U.S. Food and Drug Administration. ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 503 | displaying: 1 - 10